Anthem Bioscienc

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0CZ201020
  • NSEID: ANTHEM
  • BSEID: 544449
INR
659.35
-2.15 (-0.33%)
BSENSE

Dec 05

BSE+NSE Vol: 7.44 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Net Sales
1,844.55
1,419.37
Other Operating Income
0.00
0.00
Total Operating income
1,844.55
1,419.37
Raw Material Cost
830.62
640.79
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
-86.71
-41.24
Employee Cost
260.49
182.93
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
169.32
131.92
Total Expenditure (Excl Depreciation)
1,173.72
914.40
Operating Profit (PBDIT) excl Other Income
670.83
504.97
Other Income
85.73
63.70
Operating Profit (PBDIT)
756.56
568.67
Interest
10.33
9.54
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
746.23
559.13
Depreciation
89.37
81.82
Profit Before Tax
656.87
477.32
Tax
205.61
110.01
Provisions and contingencies
0.00
0.00
Profit After Tax
451.26
367.31
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
451.26
367.31
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
451.26
367.31
Equity Capital
111.82
111.82
Face Value
2.0
2.0
Reserves
2,298.05
1,812.84
Earnings per share (EPS)
8.07
6.57
Diluted Earnings per share
8.04
6.48
Operating Profit Margin (Excl OI)
36.37%
35.58%
Gross Profit Margin
40.46%
39.39%
PAT Margin
24.46%
25.88%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 29.85%

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2025 is 35.06%

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 36.47%

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -0.55%

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Anthem Bioscienc With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,844.55
3,749.21
-1,904.66
-50.80%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,844.55
3,749.21
-1,904.66
-50.80%
Raw Material Cost
830.62
499.90
330.72
66.16%
Purchase of Finished goods
0.00
845.11
-845.11
-100.00%
(Increase) / Decrease In Stocks
-86.71
45.85
-132.56
-289.12%
Employee Cost
260.49
579.70
-319.21
-55.06%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
169.32
601.29
-431.97
-71.84%
Total Expenditure (Excl Depreciation)
1,173.72
2,571.85
-1,398.13
-54.36%
Operating Profit (PBDIT) excl Other Income
670.83
1,177.36
-506.53
-43.02%
Other Income
85.73
145.93
-60.20
-41.25%
Operating Profit (PBDIT)
756.56
1,323.29
-566.73
-42.83%
Interest
10.33
1.31
9.02
688.55%
Exceptional Items
0.00
4.69
-4.69
-100.00%
Gross Profit (PBDT)
746.23
1,326.67
-580.44
-43.75%
Depreciation
89.37
66.79
22.58
33.81%
Profit Before Tax
656.87
1,259.88
-603.01
-47.86%
Tax
205.61
332.30
-126.69
-38.13%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
451.26
927.58
-476.32
-51.35%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
451.26
927.58
-476.32
-51.35%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
451.26
927.58
-476.32
-51.35%
Equity Capital
111.82
169.41
-57.59
-33.99%
Face Value
2.00
10.00
0.00
Reserves
2,298.05
1,781.90
516.15
28.97%
Earnings per share (EPS)
8.07
54.75
-46.68
-85.26%
Diluted Earnings per share
8.04
54.76
-46.72
-85.32%
Operating Profit Margin (Excl OI)
36.37%
31.40%
0.00
4.97%
Gross Profit Margin
40.46%
35.39%
0.00
5.07%
PAT Margin
24.46%
24.74%
0.00
-0.28%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,840.65 Cr
in Mar 2025

Figures in Cr
Annual - Standalone Net Profit
Standalone Net Profit 506.19 Cr
in Mar 2025

Figures in Cr
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 689.01 Cr
in Mar 2025

Figures in Cr
Annual - Interest
Interest 9.09 Cr
in Mar 2025

Figures in Cr
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 37.43%
in Mar 2025

Figures in %